Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease

Alzheimer's and Dementia

Volumn 2, Issue 1, 2006, Pages 43-55

  Klein, William L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Actin; Arc; Diagnostics; Glutamate receptors; Plasticity; ROS; Spines; Tau phosphorylation; Therapeutics

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; DONEPEZIL; LIGAND; MEMANTINE; OLIGOMER;

ALZHEIMER DISEASE; AMNESIA; BRAIN LEVEL; CYTOPATHOLOGY; EARLY DIAGNOSIS; HUMAN; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY; MEMORY DISORDER; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; SAMPLE; SYNAPSE; TREATMENT PLANNING;

EID: 33144484368     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2005.11.003     Document Type: Review

References (98)

1. G.W. Small P.V. Rabins P.P. Barry N.S. Buckholtz S.T. DeKosky S.H. Ferris et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society JAMA 278 16 1997 1363-1371
2. G.C. Roman S.J. Rogers Donepezil A clinical review of current and emerging indications Expert Opin Pharmacother 5 1 2004 161-180
3. A. Witt N. Macdonald P. Kirkpatrick Memantine hydrochloride Nat Rev Drug Discov 3 2 2004 109-110
4. J. Marx Alzheimer's debate boils over Science 257 5075 1992 1336-1338
5. C.J. Pike D. Burdick A.J. Walencewicz C.G. Glabe C.W. Cotman Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state J Neurosci 13 4 1993 1676-1687
6. A. Lorenzo B.A. Yankner Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red Proc Natl Acad Sci U S A 91 25 1994 12243-12247
7. W.L. Klein Aβ toxicity in Alzheimer's disease M.F. Chesselet Molecular mechanisms of neurodegenerative diseases 2001 Humana Press, Inc Totowa, New Jersey 1-49
8. M.P. Lambert G. Stevens S. Sabo K. Barber G. Wang W. Wade et al. Beta/ A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells J Neurosci Res 39 4 1994 377-385
9. J. Busciglio A. Lorenzo J. Yeh B.A. Yankner beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding Neuron 14 4 1995 879-888
10. M. Rapoport H.N. Dawson L.I. Binder M.P. Vitek A. Ferreira Tau is essential to beta-amyloid-induced neurotoxicity Proc Natl Acad Sci U S A 99 9 2002 6364-6369
11. C. Zhang M.P. Lambert C. Bunch K. Barber W.S. Wade G.A. Krafft et al. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide J Biol Chem 269 41 1994 25247-25250
12. C. Zhang H.E. Qiu G.A. Krafft W.L. Klein A beta peptide enhances focal adhesion kinase/Fyn association in a rat CNS nerve cell line Neurosci Lett 211 3 1996 187-190
13. M. Lesort R.S. Jope G.V. Johnson Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase J Neurochem 72 2 1999 576-584
14. J.A. Hardy G.A. Higgins Alzheimer's disease: The amyloid cascade hypothesis Science 256 5054 1992 184-185
15. D. Schenk R. Barbour W. Dunn G. Gordon H. Grajeda T. Guido Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 6740 1999 173-177
16. J.C. Dodart K.R. Bales K.S. Gannon S.J. Greene R.B. DeMattos C. Mathis et al. Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model Nat Neurosci 5 (5) 2002 452-457
17. L.A. Kotilinek B. Bacskai M. Westerman T. Kawarabayashi L. Younkin B.T. Hyman et al. Reversible memory loss in a mouse transgenic model of Alzheimer's disease J Neurosci 22 15 2002 6331-6335
18. R. Katzman R. Terry R. DeTeresa T. Brown P. Davies P. Fuld et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques Ann Neurol 23 2 1988 138-144
19. R.D. Terry The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations R.D. Terry R. Katzman K.L. Bick S.S. Sisodia Alzheimer disease 1999 Lippincott Williams, & Wilkins Philadelphia, PA 187-206
20. R.L. Neve N.K. Robakis Alzheimer's disease A re-examination of the amyloid hypothesis Trends Neurosci 21 1 1998 15-19
21. M. Sadowski J. Pankiewicz H. Scholtzova Y. Ji D. Quartermain C.H. Jensen Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice J Neuropathol Exp Neurol 63 5 2004 418-428
22. T. Oda G.M. Pasinetti H.H. Osterburg C. Anderson S.A. Johnson C.E. Finch Purification and characterization of brain clusterin Biochem Biophys Res Commun 204 3 1994 1131-1136
23. T. Oda P. Wals H.H. Osterburg S.A. Johnson G.M. Pasinetti T.E. Morgan et al. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress Exp Neurol 136 1 1995 22-31
24. M.P. Lambert A.K. Barlow B.A. Chromy C. Edwards R. Freed M. Liosatos et al. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc Natl Acad Sci U S A 95 11 1998 6448-6453
25. W.B. Stine Jr S.W. Snyder U.S. Ladror W.S. Wade M.F. Miller T.J. Perun et al. The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy J Protein Chem 15 2 1996 193-203
26. W.L. Klein Aβ toxicity in Alzheimer's disease Globular oligomers (ADDLs) as new vaccine and drug targets Neurochem Int 41 5 2002 345
27. M.P. Lambert K.L. Viola B.A. Chromy L. Chang T.E. Morgan J. Yu et al. Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies J Neurochem 79 3 2001 595-605
28. B.A. Chromy R.J. Nowak M.P. Lambert K.L. Viola L. Chang P.T. Velasco et al. Self-assembly of Aβ(1-42) into globular neurotoxins Biochemistry 42 44 2003 12749-12760
29. H. Levine III Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution Neurobiol Aging 16 5 1995 755-764
30. G. Bitan M.D. Kirkitadze A. Lomakin S.S. Vollers G.B. Benedek D.B. Teplow Amyloid beta -protein (Aβ) assembly: Aβ 40 and Aβ 42 oligomerize through distinct pathways Proc Natl Acad Sci U S A 100 1 2003 330-335
31. H. Levine III Alzheimer's beta-peptide oligomer formation at physiologic concentrations Anal Biochem 335 1 2004 81-90
32. L. Chang L. Bakhos Z. Wang D.L. Venton W.L. Klein Femtomole immunodetection of synthetic and endogenous Amyloid-β oligomers and its application to Alzheimer's Disease drug candidate screening J Mol Neurosci 20 3 2003 305-313
33. X. Huang C.S. Atwood R.D. Moir M.A. Hartshorn R.E. Tanzi A.I. Bush Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Aβ peptides J Biol Inorg Chem 9 8 2004 954-960
34. Boutaud O, Montine TJ, Chang L, Klein WL, Oates JA. PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid β1-42. J Biol Chem (in press).
35. H.W. Wang J.F. Pasternak H. Kuo H. Ristic M.P. Lambert B. Chromy et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus Brain Res 924 2 2002 133-140
36. Y. Gong L. Chang K.L. Viola P.N. Lacor M.P. Lambert C.E. Finch Alzheimer's disease-affected brain Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc Natl Acad Sci U S A 100 18 2003 10417-10422
37. P.N. Lacor M.C. Buniel L. Chang S.J. Fernandez Y. Gong K.L. Viola et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers J Neurosci 24 45 2004 10191-10200
38. M. Sheng S.H. Lee AMPA receptor trafficking and the control of synaptic transmission Cell 105 7 2001 825-828
39. P.N. Lacor M.C. Buniel W.L. Klein ADDLs (Aβ oligomers) alter structure and function of synaptic spines 2004 2004 Abstract Viewer/ Itinerary Planner Washington, DC: Society for Neuroscience[Online], Program No. 218.3
40. P.N. Lacor A. Sanz-Clemente K.L. Viola W.L. Klein Changes in NMDA receptor subunit 1 and 2B expression in ADDL-treated hippocampal neurons 2005 2005 Abstract Viewer/Itinerary Planner Washington, DC: Society for Neuroscience[Online], Program No. 786.17
41. E.M. Snyder Y. Nong C.G. Almeida S. Paul T. Moran E.Y. Choi Regulation of NMDA receptor trafficking by amyloid-beta Nat Neurosci 8 8 2005 1051-1058
42. H.J. Kim S.C. Chae D.K. Lee B. Chromy S.C. Lee Y.C. Park et al. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein FASEB J 17 1 2003 118-120
43. I. Nomura N. Kato T. Kita H. Takechi Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons Neurosci Lett 2005
44. D. Puzzo O. Vitolo F. Trinchese J.P. Jacob A. Palmeri O. Arancio Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/ cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity J Neurosci 25 29 2005 6887-6897
45. I. Klyubin D.M. Walsh C.A. Lemere W.K. Cullen G.M. Shankar V. Betts et al. Amyloid beta protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo Nat Med 11 5 2005 556-561
46. D.M. Walsh M. Townsend M.B. Podlisny G.M. Shankar J.V. Fadeeva O.E. Agnaf et al. Certain inhibitors of synthetic amyloid beta-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation J Neurosci 25 10 2005 2455-2462
47. B.L. Trommer C. Shah S.H. Yun G. Gamkrelidze E.S. Pasternak S.W. Blaine et al. ApoE isoform-specific effects on LTP: Blockade by oligomeric amyloid-beta1-42 Neurobiol Dis 18 1 2005 75-82
48. I. Klyubin D.M. Walsh W.K. Cullen J.V. Fadeeva R. Anwyl D.J. Selkoe et al. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo Eur J Neurosci 19 10 2004 2839-2846
49. Q. Wang D.M. Walsh M.J. Rowan D.J. Selkoe R. Anwyl Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5 J Neurosci 24 13 2004 3370-3378
50. O.V. Vitolo A. Sant'Angelo V. Costanzo F. Battaglia O. Arancio M. Shelanski Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling Proc Natl Acad Sci U S A 99 20 2002 13217-13221
51. Q.S. Chen B.L. Kagan Y. Hirakura C.W. Xie Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides J Neurosci Res 60 1 2000 65-72
52. D.A. Costello D.M. O'Leary C.E. Herron Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Aβ-mediated impairment of LTP in the hippocampus in vitro Neuropharmacology 49 3 2005 359-366
53. D.M. Walsh I. Klyubin J.V. Fadeeva W.K. Cullen R. Anwyl M.S. Wolfe et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 6880 2002 535-539
54. J. Hardy D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297 5580 2002 353-356
55. W.L. Klein Cytotoxic intermediates in the fibrillation pathway Aβ oligomers in Alzheimer's disease as a case study V. Uversky Protein misfolding, aggregation, and conformational diseases 2005 Kluwer Academic/Plenum Publishers New York, NY
56. K.A. Conway S.J. Lee J.C. Rochet T.T. Ding R.E. Williamson P.T. Lansbury Jr Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease Implications for pathogenesis and therapy Proc Natl Acad Sci U S A 97 2 2000 571-576
57. N. Reixach S. Deechongkit X. Jiang J.W. Kelly J.N. Buxbaum Tissue damage in the amyloidoses Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture Proc Natl Acad Sci U S A 101 9 2004 2817-2822
58. A.E. Butler J. Janson W.C. Soeller P.C. Butler Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes Evidence for role of islet amyloid formation rather than direct action of amyloid Diabetes 52 9 2003 2304-2314
59. Y.M. Kuo M.R. Emmerling C. Vigo-Pelfrey T.C. Kasunic J.B. Kirkpatrick G.H. Murdoch et al. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains J Biol Chem 271 8 1996 4077-4081
60. J. Frackowiak A. Zoltowska H.M. Wisniewski Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease J Neuropathol Exp Neurol 53 6 1994 637-645
61. M.P. Lambert P.N. Lacor L. Chang K.L. Viola P.T. Velasco D.K. Richardson et al. ADDL-generated monoclonal antibodies target epitopes specific to Aβ oligomers 2003 2003 Abstract Viewer/Itinerary Planner Washington, DC: Society for Neuroscience[Online], Program No. 527.16
62. Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez SJ, Lacor PN, et al. Monoclonal antibodies that target pathological assemblies of Aβ. submitted.
63. R. Kayed E. Head J.L. Thompson T.M. McIntire S.C. Milton C.W. Cotman C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 5618 2003 486-489
64. S. Oddo A. Caccamo J.D. Shepherd M.P. Murphy T.E. Golde R. Kayed Triple-transgenic model of Alzheimer's disease with plaques and tangles Intracellular Aβ and synaptic dysfunction Neuron 39 3 2003 409-421
65. S. Oddo A. Caccamo L. Tram M.P. Lambert C.G. Glabe W.L. Klein et al. Temporal profile of Aβ oligomerization in an in vivo model of Alzheimer's disease: A link between Aβ and tau pathology J Biol Chem 281 3 2006 1599-1604
66. M.A. Westerman L. Chang S. Frautschy L. Kotilinek G. Cole W. Klein Ibuprofen reverses memory loss in transgenic mice modeling Alzheimer's disease Soc Neurosci Abstr 28, 690.4 2002 10-15
67. M.M. Mesulam Neuroplasticity failure in Alzheimer's disease: Bridging the gap between plaques and tangles Neuron 24 3 1999 521-529
68. Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, et al. Temporal memory deficits in Alzheimer's mouse models: Rescue by genetic deletion of BACE1 with reduced amyloid-β oligomers. Eur J Neurosci. In press.
69. E.H. Bigio M.P. Lambert P. Shaw P.N. Lacor K.L. Viola W.L. Klein Aβ oligomers in aging and Alzheimer disease J Neuropathol Exp Neurol 64 5 2005 440
70. R.H. Takahashi C.G. Almeida P.F. Kearney F. Yu M.T. Lin T.A. Milner et al. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain J Neurosci 24 14 2004 3592-3599
71. W.E. Klunk H. Engler A. Nordberg Y. Wang G. Blomqvist D.P. Holt et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann Neurol 55 3 2004 306-319
72. Montalto MC, Agdeppa ED, Siclovan TM, Williams AC. Composition and methods for non-invasive imaging of soluble beta-amyloid. New York/USA patent US 2004/0223909 A1. 2004 Nov 2004.
73. D.G. Georganopoulou L. Chang J.M. Nam C.S. Thaxton E.J. Mufson W.L. Klein et al. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease Proc Natl Acad Sci U S A 102 7 2005 2273-2276
74. D.W. Allison A.S. Chervin V.I. Gelfand A.M. Craig Postsynaptic scaffolds of excitatory and inhibitory synapses in hippocampal neurons: maintenance of core components independent of actin filaments and microtubules J Neurosci 20 12 2000 4545-4554
75. H.J. Carlisle M.B. Kennedy Spine architecture and synaptic plasticity Trends Neurosci 28 4 2005 182-187
76. M. Matsuzaki G.C. Ellis-Davies T. Nemoto Y. Miyashita M. Iino H. Kasai Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons Nat Neurosci 4 11 2001 1086-1092
77. J.C. Fiala J. Spacek K.M. Harris Dendritic spine pathology: Cause or consequence of neurological disorders? Brain Res Brain Res Rev 39 1 2002 29-54
78. F. Calon G.P. Lim F. Yang T. Morihara B. Teter O. Ubeda et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model Neuron 43 5 2004 633-645
79. L.A. Horrocks Y.K. Yeo Health benefits of docosahexaenoic acid (DHA) Pharmacol Res 40 3 1999 211-225
80. A.M. Tully H.M. Roche R. Doyle C. Fallon I. Bruce B. Lawlor et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease A case-control study Br J Nutr 89 4 2003 483-489
81. J.F. Guzowski G.L. Lyford G.D. Stevenson F.P. Houston J.L. McGaugh P.F. Worley et al. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory J Neurosci 20 11 2000 3993-4001
82. O. Steward P. Worley Local synthesis of proteins at synaptic sites on dendrites Role in synaptic plasticity and memory consolidation? Neurobiol Learn Mem 78 3 2002 508-527
83. J.F. Guzowski Insights into immediate-early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches Hippocampus 12 1 2002 86-104
84. M.P. Kelly S.A. Deadwyler Experience-dependent regulation of the immediate-early gene arc differs across brain regions J Neurosci 23 16 2003 6443-6451
85. E.M. Rial Verde P. Worley R. Malinow H.T. Cline The immediate-early gene Arc regulates AMPA_receptor trafficking Soc Neurosci Abstr 29 55.7 2003 10-15
86. J.J. Palop J. Chin N. Bien-Ly C. Massaro B.Z. Yeung G.Q. Yu et al. Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice J Neurosci 25 42 2005 9686-9693
87. L. Mucke E. Masliah G.Q. Yu M. Mallory E.M. Rockenstein G. Tatsuno et al. High-level neuronal expression of Aβ 1-42 in wild-type human amyloid protein precursor transgenic mice Synaptotoxicity without plaque formation J Neurosci 20 11 2000 4050-4058
88. L. Tong P.L. Thornton R. Balazs C.W. Cotman Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised J Biol Chem 276 20 2001 17301-17306
89. V.D. Longo K.L. Viola W.L. Klein C.E. Finch Reversible inactivation of superoxide-sensitive aconitase in Aβ1-42-treated neuronal cell lines J Neurochem 75 5 2000 1977-1985
90. C.W. Cotman N.C. Berchtold Exercise A behavioral intervention to enhance brain health and plasticity Trends Neurosci 25 6 2002 295-301
91. Y. Yin G.M. Edelman P.W. Vanderklish The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes Proc Natl Acad Sci U S A 99 4 2002 2368-2373
92. S.B. Peres S.M. de Moraes C.E. Costa L.C. Brito J. Takada S. Andreotti et al. Endurance exercise training increases insulin responsiveness in isolated adipocytes through IRS/PI3-kinase/Akt pathway J Appl Physiol 98 3 2005 1037-1043
93. D.J. Selkoe Normal and abnormal biologyof the beta-amyloid precursor protein Annu Rev Neurosci 17 1994 489-517
94. S.J. Pollack H. Lewis Secretase inhibitors for Alzheimer's disease challenges of a promiscuous protease Curr Opin Investig Drugs 6 1 2005 35-47
95. I. Ferrer R.M. Boada M.L. Sanchez Guerra M.J. Rey F. Costa-Jussa Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease Brain Pathol 14 1 2004 11-20
96. W.L. Klein G.A. Krafft C.E. Finch Targeting small Aβ oligomers The solution to an Alzheimer's disease conundrum? Trends Neurosci 24 4 2001 219-224
97. F.G. De Felice M.N. Vieira L.M. Saraiva J.D. Figueroa-Villar J. Garcia-Abreu R. Liu et al. Targeting the neurotoxic species in Alzheimer's disease Inhibitors of Aβ oligomerization FASEB J 18 12 2004 1366-1372
98. Z. Wang L. Chang W.L. Klein G.R. Thatcher D.L. Venton Per-6-substituted-per-6-deoxy beta-cyclodextrins inhibit the formation of beta-amyloid peptide derived soluble oligomers J Med Chem 47 13 2004 3329-3333